CD8A and neoplasm: For example, we and others have applied scRNA/TCR-seq to show that peripherally expanded, tumor-specific CD8+ T cell clones replace dysfunctional exhausted T cells in the tumor, which is essential to immune checkpoint blockade response3–5.